首页 > 最新文献

Turk Onkoloji Dergisi-Turkish Journal of Oncology最新文献

英文 中文
Clinical Outcome and Characteristics of Turkish Breast Cancer Patients who had SARS-Cov-2 Infection 土耳其乳腺癌合并SARS-Cov-2感染患者的临床结局和特点
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3692
A. Isiklar
OBJECTIVE COVID-19 pandemic has placed an unprecedented burden on health-care system. Patients with cancer are reported to have a higher risk of infection and a more complicated COVID-19 course. Breast cancer (BC) is the most common cancer in women in Turkey. We report clinical outcomes and characteristics of patients with COVID-19 who were on treatment for BC at our center. METHODS We reviewed medical records of BC patients who had COVID-19 between July 2020 and 2021 at our center. We recorded pathological, clinical, treatment characteristics, and the clinical outcome of COVID-19 infection. RESULTS A total 82 BC patients had COVID-19 between July 2020 and 2021. All patients were female, with a median age of 49 (43-64 years). 85% of all patients had early and 14.6% of them had advanced stage BC. COVID-19 had a mild clinical course in 73%, hospitalization was required in 27% of patients. Twenty-five patients who required hospitalization were discharged and three patients died due to COVID-19. All of the patients who died from COVID-19 had metastatic BC (p=0.002). Metastatic disease (p=0.002) and chemotherapy within 7 days of COVID-19 diagnosis (p=0.024) have been associated with increased mortality. CONCLUSION Majority of BC patients with COVID-19 have a mild course, patients with risk factors that increase mortality should be followed more carefully.
2019冠状病毒病大流行给卫生保健系统带来了前所未有的负担。据报道,癌症患者感染的风险更高,COVID-19的病程也更复杂。乳腺癌(BC)是土耳其妇女中最常见的癌症。我们报告了在我们中心接受BC治疗的COVID-19患者的临床结果和特征。方法:我们回顾了2020年7月至2021年7月在我们中心感染COVID-19的BC患者的医疗记录。我们记录了COVID-19感染的病理、临床、治疗特点和临床转归。结果在2020年7月至2021年7月期间,共有82例BC患者感染了COVID-19。所有患者均为女性,中位年龄为49岁(43-64岁)。85%的患者为早期BC, 14.6%为晚期BC。73%的患者临床病程轻微,27%的患者需要住院治疗。25名需要住院治疗的患者出院,3名患者死亡。所有死于COVID-19的患者都有转移性BC (p=0.002)。转移性疾病(p=0.002)和COVID-19诊断后7天内的化疗(p=0.024)与死亡率增加相关。结论BC省新冠肺炎患者病程以轻症为主,对存在增加死亡率危险因素的患者应加强随访。
{"title":"Clinical Outcome and Characteristics of Turkish Breast Cancer Patients who had SARS-Cov-2 Infection","authors":"A. Isiklar","doi":"10.5505/tjo.2022.3692","DOIUrl":"https://doi.org/10.5505/tjo.2022.3692","url":null,"abstract":"OBJECTIVE COVID-19 pandemic has placed an unprecedented burden on health-care system. Patients with cancer are reported to have a higher risk of infection and a more complicated COVID-19 course. Breast cancer (BC) is the most common cancer in women in Turkey. We report clinical outcomes and characteristics of patients with COVID-19 who were on treatment for BC at our center. METHODS We reviewed medical records of BC patients who had COVID-19 between July 2020 and 2021 at our center. We recorded pathological, clinical, treatment characteristics, and the clinical outcome of COVID-19 infection. RESULTS A total 82 BC patients had COVID-19 between July 2020 and 2021. All patients were female, with a median age of 49 (43-64 years). 85% of all patients had early and 14.6% of them had advanced stage BC. COVID-19 had a mild clinical course in 73%, hospitalization was required in 27% of patients. Twenty-five patients who required hospitalization were discharged and three patients died due to COVID-19. All of the patients who died from COVID-19 had metastatic BC (p=0.002). Metastatic disease (p=0.002) and chemotherapy within 7 days of COVID-19 diagnosis (p=0.024) have been associated with increased mortality. CONCLUSION Majority of BC patients with COVID-19 have a mild course, patients with risk factors that increase mortality should be followed more carefully.","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric Evaluation of Total Body Irradiations with Helical Tomotherapy: Phantom Study 螺旋断层治疗的全身照射剂量学评价:幻影研究
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3722
G. Ucar Alveroglu
{"title":"Dosimetric Evaluation of Total Body Irradiations with Helical Tomotherapy: Phantom Study","authors":"G. Ucar Alveroglu","doi":"10.5505/tjo.2022.3722","DOIUrl":"https://doi.org/10.5505/tjo.2022.3722","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperarc VMAT Technique in the Treatment of Thyroid Ophthalmopathy 超弧度VMAT技术治疗甲状腺性眼病
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3419
Tarık Kargıoğlu
{"title":"Hyperarc VMAT Technique in the Treatment of Thyroid Ophthalmopathy","authors":"Tarık Kargıoğlu","doi":"10.5505/tjo.2022.3419","DOIUrl":"https://doi.org/10.5505/tjo.2022.3419","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"149 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cisplatin and Etoposide with Concurrent Radiotherapy in Locally Advanced Thymic Carcinoma 顺铂和依托泊苷联合放疗治疗局部晚期胸腺癌
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3450
G. Uslu
{"title":"Cisplatin and Etoposide with Concurrent Radiotherapy in Locally Advanced Thymic Carcinoma","authors":"G. Uslu","doi":"10.5505/tjo.2022.3450","DOIUrl":"https://doi.org/10.5505/tjo.2022.3450","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"125 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pattern of Recurrence and Survival Outcomes in Non-Metastatic Triple-Negative Breast Cancer; A Retrospective Analysis 非转移性三阴性乳腺癌的复发模式和生存结局回顾性分析
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3458
jayaraman kannan
{"title":"Pattern of Recurrence and Survival Outcomes in Non-Metastatic Triple-Negative Breast Cancer; A Retrospective Analysis","authors":"jayaraman kannan","doi":"10.5505/tjo.2022.3458","DOIUrl":"https://doi.org/10.5505/tjo.2022.3458","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"228 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-Treatment and Post-Treatment Neutrophil-to- Lymphocyte Ratio Predict Pathological Tumor Response and Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 治疗前后中性粒细胞与淋巴细胞比值预测直肠癌新辅助放化疗患者的病理肿瘤反应和生存
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3467
E. Soykut
{"title":"Pre-Treatment and Post-Treatment Neutrophil-to- Lymphocyte Ratio Predict Pathological Tumor Response and Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy","authors":"E. Soykut","doi":"10.5505/tjo.2022.3467","DOIUrl":"https://doi.org/10.5505/tjo.2022.3467","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lumpectomy with or without Irradiation in Women 70 Years of Age or Older with the Early Breast Cancer 70岁及以上早期乳腺癌患者的乳房肿瘤切除术加或不加放疗
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3594
Gulnihan Eren
{"title":"Lumpectomy with or without Irradiation in Women 70 Years of Age or Older with the Early Breast Cancer","authors":"Gulnihan Eren","doi":"10.5505/tjo.2022.3594","DOIUrl":"https://doi.org/10.5505/tjo.2022.3594","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Proptosis due to Myeloid Sarcoma, Dramatic Recovery with Chemotherapy: A Case Report 髓系肉瘤所致严重增生,化疗后显著恢复1例
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3663
ayşe özkan karagenç
{"title":"Severe Proptosis due to Myeloid Sarcoma, Dramatic Recovery with Chemotherapy: A Case Report","authors":"ayşe özkan karagenç","doi":"10.5505/tjo.2022.3663","DOIUrl":"https://doi.org/10.5505/tjo.2022.3663","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Surgical Resection Extent on Boost Volume Changes During Radiotherapy for Glioblastoma 手术切除程度对胶质母细胞瘤放疗期间增强体积变化的影响
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3841
E. Tezcanli
{"title":"The Effect of Surgical Resection Extent on Boost Volume Changes During Radiotherapy for Glioblastoma","authors":"E. Tezcanli","doi":"10.5505/tjo.2022.3841","DOIUrl":"https://doi.org/10.5505/tjo.2022.3841","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging 18F-FDG PET/CT表现及CA-125水平在卵巢癌分期中的研究
IF 0.3 Q4 ONCOLOGY Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3431
Reşit Akyel
{"title":"Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging","authors":"Reşit Akyel","doi":"10.5505/tjo.2022.3431","DOIUrl":"https://doi.org/10.5505/tjo.2022.3431","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"1 1","pages":""},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Onkoloji Dergisi-Turkish Journal of Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1